Delivery Order 75N92019D00033-75N92019F00074

Award Date 4/1/19
Potential Completion Date 3/31/24
Potential Value $8.4M
Awardee
Vitalant
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
San Francisco, CA 94118, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2 project, awarded by the National Heart Lung and Blood Institute (NHLBI) to the prime contractor, Vitalant Research Institute (VRI), a nonprofit organization. The $4,908,528.00 cost-type delivery order contract has a completion date of March 31, 2025. VRI, the research arm of the nonprofit blood services provider Vitalant, will conduct the study in collaboration with the University of...
This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Vitalant, a nonprofit organization that provides blood products and conducts research related to transfusion medicine. The contract, titled "REDS-III" (Recipient Epidemiology and Donor Evaluation Study - III), has a ceiling value of $8,847,513.18 and a period of performance ending on December 31, 2019. The contract does not have a set-aside...
This is a $1,590,903.99 delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) within the Department of Health and Human Services (HHS) to the nonprofit organization Vitalant, doing business as Vitalant Research Institute (VRI). The contract is for the REDS-IV-P Domestic Hubs - Phase 1 project and does not have a set-aside designation. VRI, the research division of Vitalant, is serving as the prime contractor and is partnering with subcontractors including the...
This is a $2,206,818.78 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Vitalant (formerly Blood Systems), a nonprofit organization, to conduct clinical and epidemiological research on transfusion safety concerns as part of the REDS-IV-P Brazil Phase 1 program. The contract does not have a set-aside designation. Vitalant's research division, the Vitalant Research Institute (VRI), is the prime contractor. VRI has subcontracted with...
This is a $493,905.79 delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute to The Institute For Transfusion Medicine, doing business as Vitalant Research Institute (a division of the nonprofit organization Vitalant). The order is for the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) - Phase 3 - Domestic Site and has a completion date of December 31, 2019. The contract type is Cost No...
This is a $2,702,179.00 delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Vitalant Research Institute (VRI), the research arm of nonprofit organization Vitalant. The contract, titled "REDS-IV-P BRAZIL HUB", does not have a set-aside designation and has a performance period ending on June 30, 2026. VRI is an experienced federal contractor that has held multiple Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded Vitalant Research Institute a $727,897 delivery order contract to support the Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Central Laboratory program. Under the cost-no-fee contract, Vitalant will provide laboratory services from its facilities in San Francisco, California through December 2019 to assist NIH's ongoing research efforts aimed at improving...
This federal contract award is for the delivery of REDS-IV-P DOMESTIC HUBS to the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. Government. The $1,656,613.00 contract was awarded to the non-profit organization Versiti Wisconsin, Inc. on July 1, 2024, with a completion date of June 30, 2026. The contract is a Delivery Order with a Cost No Fee pricing type. There is no set-aside designation for this award. Versiti Wisconsin, Inc. is a long-standing federal...
This is a $4,332,504.00 delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to Vitalant Research Institute (VRI), a non-profit organization, for the REDS-IV-P BRAZIL TRANSFUSION SAFETY RESEARCH PROGRAM PHASE 2. The contract is not set aside. VRI will provide clinical and scientific input, including data analysis and protocol development, for a study on linked donor-component-recipient outcomes in blood transfusions in Brazil. VRI has also received federal...
This is a federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Research Triangle Institute (RTI International), a non-profit research organization. The $5,737,866.07 contract is for the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) Data Coordinating Center, a delivery order contract with a cost-plus-fixed-fee pricing type. The contract has no set-aside designation. As part of this contract, RTI International has subcontracted...
  • 75N92019D00033
    Indefinite Delivery Contract
  • 75N92019D00033-75N92019F00074
    Delivery Order

This is a $8,446,747.46 federal delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to Vitalant, a non-profit organization. The contract is for the REDS-IV-P - Center for Transfusion Laboratory Studies (CTLS), Phase 1, which involves necessary testing and serving as the biospecimen repository for the REDS-IV-P program.

The University of Colorado-Denver is a major subcontractor on this contract, responsible for the testing conducted in the U.S. and serving as the REDS-IV-P biospecimen repository. The contract has no set-aside designation and is being performed as a cost-no-fee arrangement. This award is part of the REDS-IV-P program, which is an ongoing transfusion medicine research initiative supported by the NHLBI to improve the safety and availability of the U.S. blood supply.

Generated 8/8/24, 9:54 AM